Poly adenosine disphosphate-ribose polymerase (PARP) inhibitors systemic medication codes
Metadata
- Coding system
- Dictionary of Medicines and Devices
- Coding system release
- 2025 10.1.0
- Organisation
- NHS Drug Refsets
- Codelist ID
- nhs-drug-refsets/parpdrug_cod
- Version Tag
- 20250627
- Version ID
- 6f14eeac
- Number of codes included
- 25
About
Description
Taken from the `PARPDRUG_COD` NHS drug refset. Contains public sector information licensed under the UK Open Government Licence v3.0 (https://www.nationalarchives.gov.uk/doc/open-government-licence/version/3/).
Codelists are developed by a broad community of users for individual study purposes, which may or may not meet the needs of other studies. They should not be thought of as universal definitions of a particular condition.
We don't offer any guarantees about what they do or don't identify. Users should carefully check that any codelist meets their needs, and seek clinical input where appropriate.
* dm+d codelists can be downloaded with codes mapped to changed VMPs included - this is the default for an OpenSAFELY project. See the documentation on keeping codelists up to date for more details.
| code | term |
|---|---|
| 29747411000001106 | Lynparza 50mg capsules (AstraZeneca UK Ltd) (AMP) |
| 29768811000001101 | Olaparib 50mg capsules (VMP) |
| 35017411000001108 | Zejula 100mg capsules (GlaxoSmithKline UK Ltd) (AMP) |
| 35018311000001100 | Niraparib 100mg capsules (VMP) |
| 35498711000001106 | Lynparza 100mg tablets (AstraZeneca UK Ltd) (AMP) |
| 35499011000001104 | Lynparza 150mg tablets (AstraZeneca UK Ltd) (AMP) |
| 35514811000001103 | Olaparib 100mg tablets (VMP) |
| 35514911000001108 | Olaparib 150mg tablets (VMP) |
| 35819211000001104 | Rucaparib 200mg tablets (VMP) |
| 35819411000001100 | Rubraca 200mg tablets (pharmaand GmbH) (AMP) |
| 35819611000001102 | Rucaparib 250mg tablets (VMP) |
| 35819811000001103 | Rubraca 250mg tablets (pharmaand GmbH) (AMP) |
| 35820011000001105 | Rucaparib 300mg tablets (VMP) |
| 35820211000001100 | Rubraca 300mg tablets (pharmaand GmbH) (AMP) |
| 37649611000001100 | Talzenna 0.25mg capsules (Pfizer Ltd) (AMP) |
| 37650611000001109 | Talzenna 1mg capsules (Pfizer Ltd) (AMP) |
| 37723111000001100 | Talazoparib 1mg capsules (VMP) |
| 37723211000001106 | Talazoparib 250microgram capsules (VMP) |
| 38374011000001106 | Zejula 100mg capsules (Originalis B.V.) (AMP) |
| 39240511000001100 | Lynparza 100mg tablets (Originalis B.V.) (AMP) |
| 39240711000001105 | Lynparza 150mg tablets (Originalis B.V.) (AMP) |
| 41448211000001105 | Zejula 100mg tablets (GlaxoSmithKline UK Ltd) (AMP) |
| 41546111000001107 | Niraparib 100mg tablets (VMP) |
| 42997511000001103 | Talzenna 0.1mg capsules (Pfizer Ltd) (AMP) |
| 43008411000001103 | Talazoparib 100microgram capsules (VMP) |
* Note that this is the full list of explicitly included dm+d codes for this codelist. An OpenSAFELY project will by default also include previous or subsequent codes for any included VMPs that may have changed code. See the documentation on keeping codelists up to date for more details.